» Download Public Reports
12 reports
- Company report
- March 2011
- 22 pages
... For frequent- user, insulin-dependent diabetics. pharmacies netherlands: o decrease of sales (- 9%) and ebita (- 78%) due to lagging volumes, strong price pressure and higher costs; market conditions have ...
March 2011
... For frequent- user, insulin-dependent diabetics. pharmacies netherlands: o decrease of sales (- 9%) and ebita (- 78%) due to lagging volumes, strong price pressure and higher costs; market conditions have ...
March 2011
... Expect that decrease to be substantial. The outlook for d&i and pharmacies poland is unchanged; at both segments we expect an increase in ebita. Operational highlights direct & institutional ...
March 2011
... Center in usa consold as of 31 may. pharmacies netherlands Sales and ebita down due to substantially lower prices and lower volumes than expected; poor market conditions continue. Outcome ...
March 2011
... To 21.9 Million; mainly as a result of the declining sales from pharmaceuticals and the restructuring provision ( 3.1 Million) at pharmacies netherlands. Net result amounted to 0.9 Million due ...
March 2011
... Expect that decrease to be substantial. The outlook for d&i and pharmacies poland is unchanged; at both segments we expect an increase in ebita. Operational highlights direct & institutional ...
February 2011
... And preference policy; will be largely offset by cost savings and volume growth pharmacies poland Revenue growth in line with market Increase in profitability at both retail and wholesale operations 25 ...
June 2012
... Directly linked the disease with its impact on the retail pharmacy sector. Boom and post boom economical effects are felt on the ability to procure labour in pharmacies as a result of the dutch ...